Skip to content

GRCE

Grace Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.88
−0.53%
Ask drillr
18
Insider buys (3m)
0
Insider sells (3m)
$639.6K
Net value (3m)
-24.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Oct 16, 2026Opaleye Management Inc. · 10 percent ownerPurchase11,233$1.93
Oct 16, 2026Opaleye Management Inc. · 10 percent ownerPurchase36,347$1.89
Oct 16, 2026Opaleye Management Inc. · 10 percent ownerPurchase23,485$1.95
Oct 13, 2026Opaleye Management Inc. · 10 percent ownerPurchase7,215$2.02
Oct 13, 2026Opaleye Management Inc. · 10 percent ownerPurchase5,340$2.04
Oct 13, 2026Opaleye Management Inc. · 10 percent ownerPurchase2,077$2.02
Oct 5, 2026Opaleye Management Inc. · 10 percent ownerPurchase38,796$2.04
Oct 5, 2026Opaleye Management Inc. · 10 percent ownerPurchase1,694$2.06
Oct 5, 2026Opaleye Management Inc. · 10 percent ownerPurchase20,000$2.07
Oct 1, 2026Opaleye Management Inc. · 10 percent ownerPurchase5,318$2.10
Oct 1, 2026Opaleye Management Inc. · 10 percent ownerPurchase9,771$2.10
Oct 1, 2026Opaleye Management Inc. · 10 percent ownerPurchase7,849$2.09
Sep 23, 2026Opaleye Management Inc. · 10 percent ownerPurchase9,771$2.10
Sep 23, 2026Opaleye Management Inc. · 10 percent ownerPurchase5,318$2.10
Sep 21, 2026DAVIS A BRIAN · directorA-Award0$2.13
Sep 21, 2026Kottayil George · directorA-Award12,200$2.13
Sep 21, 2026Kavuru Vimal · directorA-Award12,200$2.13
Sep 21, 2026NEUGEBOREN EDWARD · directorA-Award12,200$2.13
Sep 10, 2026Opaleye Management Inc. · 10 percent ownerPurchase5,836$2.09
Sep 10, 2026Opaleye Management Inc. · 10 percent ownerPurchase9,393$2.10
Sep 10, 2026Kohli Prashant · director, officer: Chief Executive OfficerPurchase100,000$2.14
Sep 1, 2026DelAversano Robert J · officer: Principal Financial OfficerA-Award33,660$2.12
Sep 1, 2026Macdonald R. Loch · officer: Chief Medical OfficerA-Award54,690$2.12
Sep 1, 2026Kohli Prashant · director, officer: Chief Executive OfficerA-Award267,160$2.12
Sep 1, 2026Kumar Amresh · officer: VP Program ManagementA-Award35,760$2.12
Aug 19, 2026Opaleye Management Inc. · 10 percent ownerPurchase11,608$2.09
Jan 12, 2026Kavuru Vimal · directorA-Award10,000$3.80
Jan 12, 2026DAVIS A BRIAN · directorA-Award10,000$3.80
Jan 12, 2026NEUGEBOREN EDWARD · directorA-Award10,000$3.80
Jan 12, 2026Kottayil George · directorA-Award10,000$3.80
Institutional positioning

13F filings over the trailing two quarters

New 28Increased 18Reduced 9Sold out 12
FilerActionSharesFiled
CERITY PARTNERS LLCIncreased849,055May 15, 2026
Cerity Partners LLCUnchanged849,055Aug 14, 2026
Eversept Partners, LPIncreased772,900Aug 14, 2026
EVERSEPT PARTNERS, LPNew Position756,600May 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCReduced728,203May 15, 2026
BANK OF AMERICA CORP /DE/Increased494,723May 18, 2026
BANK OF AMERICA CORP /DE/Reduced494,698Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased411,714Aug 13, 2026
CITADEL ADVISORS LLCIncreased402,240Sep 2, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position401,656May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased243,910May 14, 2026
Maven Securities LTDNew Position200,000Aug 14, 2026
JANE STREET GROUP, LLCNew Position167,097May 12, 2026
JANE STREET GROUP, LLCReduced161,542Aug 14, 2026
Birchview Capital, LPIncreased120,000Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 16, 2026